PDCD1 and B-cell chronic lymphocytic leukemia: In Chronic Lymphocytic Leukemia (CLL), monocytes exhibit high levels of PD-1, which disrupts their glucose metabolism and weakens their immune functions, fostering an immunosuppressive environment that promotes leukemia progression (158).